Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Thursday newspaper round-up: Merck, North Sea, life sciences

(Sharecast News) - The US drugmaker Merck has scrapped a £1bn London research centre and is laying off 125 scientists in the capital this year, in a big blow to the UK's important life science sector. Keir Starmer's government has described life sciences as "one of the crown jewels of the UK economy" and the previous Conservative government had vowed to turn the country into a "global science and technology superpower" by 2030. - Guardian

The chancellor, Rachel Reeves, has told private equity bosses that she plans to shut down more regulators across the UK as she attempts to drive growth across Britain's subdued economy. Reeves - who in July claimed regulators were a "boot on the neck" of business - highlighted her recent decisions to sack the chair of the competitions watchdog, shut down the payments regulator, and "severely" constrain the Financial Ombudsman Service, which UK banks have long lobbied to curtail. However, she said there was "still more to do". - Guardian

Ed Miliband must embrace the declining North Sea by offering subsidies to oil and gas companies operating in the basin, Dale Vince has said. Mr Vince, the green energy tycoon who is also a Labour donor, said companies that operate in the North Sea should be given a guaranteed minimum price per barrel of oil and gas to put them on an equal footing with renewable energy providers. - Telegraph

The UK is "losing the race" to attract global investment into its key life sciences and pharmaceutical sectors due to an uncompetitive operating environment, the pharmaceuticals industry has warned amid a stand-off with the government. The critical report from the Association of the British Pharmaceutical Industry "lays bare" the country's drop in rankings in attracting foreign direct investment and commercial clinical trials. - The Times

Share this article

Related Sharecast Articles

Tuesday newspaper round-up: consumer confidence, easyJet, Thames Water
(Sharecast News) - Consumer confidence hit its highest level in almost two years in July, according to research that indicated the closing stages of the men's football World Cup and more people holidaying in the UK lifted summer spending. A truce in the Middle East conflict in June and the arrival of a new prime minister in No 10 also gave a lift to consumers after a long period of heightened uncertainty. A long-running monthly consumer spending survey by Barclays showed that 30% of those surveyed felt confident about the strength of the UK economy in July - representing a 21-month high and a six-percentage-point improvement on June. - Guardian
Monday newspaper round-up: Harvey Nichols, Heathrow, Lloyds Banking Group
(Sharecast News) - Andy Burnham has promised a series of measures to tackle the cost of living, including a ban on fake discounts and making it easier for people to escape unwanted subscriptions. The crackdown on "rip-off" business practices is expected to benefit consumers to the tune of £400m a year and will be the first in a range of "everyday fixes" to be implemented in the coming months. - Guardian
Friday newspaper round-up: Gas power stations, Apple, Raleigh
(Sharecast News) - Trains across parts of north-west England have ground to a halt after a power failure hit the signalling centre controlling the railway in the region. Passengers awaiting Northern and TransPennine trains have been advised not to travel, with widespread cancellations and other services delayed by more than an hour already. - Guardian
Thursday newspaper round-up: AI models, bank taxes, AstraZeneca
(Sharecast News) - Advanced artificial intelligence models have stunned the UK's AI Security Institute (AISI) by carrying out a hacking campaign against real people during a cybersecurity test. The institute said the incident was unprecedented and involved sending targeted emails to software developers in an attempt to pass a cyber challenge. - Guardian

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.